APA (7th ed.) Citation

Engel T, Smith J, & Alves M. (2021). Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy. Dove Medical Press.

Chicago Style (17th ed.) Citation

Engel T, Smith J, and Alves M. Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy. Dove Medical Press, 2021.

MLA (9th ed.) Citation

Engel T, et al. Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy. Dove Medical Press, 2021.